Evidence map›Paper›PMID 33155388›Full record

ArticleCancer science2021

Sublethal irradiation promotes the metastatic potential of hepatocellular carcinoma cells.

Yulin Cao, Yuan Yin, Xue Wang, Zhifeng Wu, Yuhang Liu, Fuzheng Zhang, Junhua Lin, Zhaohui Huang, Leyuan Zhou

Open access · goldAbstract read
In one paragraph

Article in Cancer science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Radiation-induced liver disease: beyond DNA damage.Cell cycle (Georgetown, Tex.) · 2023
    Review
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Yulin CaoDepartment of Radiation Oncology, Affiliated Hospital of Jiangnan University, Wuxi, China.
Yuan YinWuxi Cancer Institute, Affiliated Hospital of Jiangnan University, Wuxi, China.
Xue WangLaboratory of Cancer Epigenetics, Wuxi School of Medicine, Jiangnan University, Wuxi, China.
Zhifeng WuExperimental Research Center, Zhongshan Hospital, Fudan University, Shanghai, China.
Yuhang LiuWuxi Cancer Institute, Affiliated Hospital of Jiangnan University, Wuxi, China.
Fuzheng ZhangDepartment of Radiation Oncology, Affiliated Hospital of Jiangnan University, Wuxi, China.
Junhua LinDepartment of Radiation Oncology, Affiliated Hospital of Jiangnan University, Wuxi, China.
Zhaohui HuangWuxi Cancer Institute, Affiliated Hospital of Jiangnan University, Wuxi, China.ORCID https://orcid.org/0000-0002-0117-9976
Leyuan ZhouDepartment of Radiation Oncology, Affiliated Hospital of Jiangnan University, Wuxi, China.
Jiangnan University · CNFudan University · CN

Funding

Double hundred Medical Professionals Program of Wuxi BJ2020053Double hundred Medical Professionals Program of Wuxi BJ2020058High level health talent project of Jiangsu Province LGY2018012High level health talent project of Jiangsu Province LGY2019017Medical Innovation Team Program of Wuxi CXTP003Medical Key Professionals Program of Jiangsu Province AF052141Medical Key Professionals Program of Wuxi ZDRC013Medical Youth Professionals Program of Jiangsu Province QNRC2016162National Natural Science Foundation of China 81301920National Natural Science Foundation of China 81672328National Natural Science Foundation of China 81772636National Natural Science Foundation of China 81972220Six Talent Peaks Projects of Jiangsu Province WSW-155Six Talent Peaks Projects of Jiangsu Province WSW-196Social Development Project of Jiangsu Province BE2019632
6 · The paper itself

Abstract

Radiotherapy (RT) represents one of the major treatment methods for cancers. However, many studies have observed that in descendant surviving tumor cells, sublethal irradiation can promote metastatic ability, which is closely related to the tumor microenvironment. We therefore investigated the functions and mechanisms of sublethal irradiated liver nonparenchymal cells (NPCs) in hepatocellular carcinoma (HCC). In this study, primary rat NPCs and McA-RH7777 hepatoma cells were irradiated with 6 Gy X-ray. Conditioned media (CM) from nonirradiated (SnonR), irradiated (SR), or irradiated plus radiosensitizer celecoxib-treated (S[R + D]) NPCs were collected and added to sublethal irradiated McA-RH7777 cells. We showed that CM from sublethal irradiated NPCs significantly promoted the migration and invasion ability of sublethal irradiated McA-RH7777 cells, which was reversed by celecoxib. The differentially expressed genes in differently treated McA-RH7777 cells were enriched mostly in the AMP-activated protein kinase/mammalian target of rapamycin (AMPK/mTOR) signaling pathway. SR increased the migration and invasion ability of HCC cells by inhibiting AMPK/mTOR signaling, which was enhanced by the AMPK inhibitor compound C and blocked by the AMPK activator GSK-621. Analyses of HCC tissues after neoadjuvant radiotherapy confirmed the effects of radiation on the AMPK/mTOR pathway. Cytokine antibody arrays and further functional investigations showed that matrix metalloproteinase-8 (MMP-8) partly mediates the promotion effects of SR on the migration and invasion ability of HCC cells by regulating AMPK/mTOR signaling. In summary, our data indicate that MMP-8 secreted by irradiated NPCs enhanced the migration and invasion of HCC by regulating AMPK/mTOR signaling, revealing a novel mechanism mediating sublethal irradiation-induced HCC metastasis at the level of the tumor microenvironment.

Indexed as

AnimalsCarcinoma, HepatocellularCell Line, TumorCell MovementLiverLiver NeoplasmsMaleMatrix Metalloproteinase 8Neoplasm InvasivenessRatsRats, Sprague-DawleySignal TransductionX-RaysMatrix Metalloproteinase 8Mmp8 protein, ratcytokinehepatocellular carcinoma cellsmetastasisradiotherapysublethal irradiation

Identifiers

PMID33155388
PMCPMC7780048
OpenAlexW3096286457

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.